Cytotoxic T cells and viral hepatitis.
作者信息
Chisari F V
机构信息
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
出版信息
J Clin Invest. 1997 Apr 1;99(7):1472-7. doi: 10.1172/JCI119308.
Abstract
摘要
相似文献
1
Cytotoxic T cells and viral hepatitis.细胞毒性T细胞与病毒性肝炎
J Clin Invest. 1997 Apr 1;99(7):1472-7. doi: 10.1172/JCI119308.
2
[The role of hepatitis B and C virus-specific CTL in the control of viral replication].[乙型和丙型肝炎病毒特异性细胞毒性T淋巴细胞在控制病毒复制中的作用]
Nihon Rinsho Meneki Gakkai Kaishi. 2002 Feb;25(1):79-88.
3
[Chronicity and immunology of viral hepatitis].[病毒性肝炎的慢性化与免疫学]
Nihon Naika Gakkai Zasshi. 1993 Sep 10;82(9):1399-402.
4
[Immunopathogenic aspects of chronic viral hepatitis].
Rev Clin Esp. 1996 Mar;196(3):179-84.
5
Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
Curr Opin Immunol. 2000 Aug;12(4):403-8. doi: 10.1016/s0952-7915(00)00108-4.
6
HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
Hepatology. 1993 Nov;18(5):1039-44.
7
[Cellular immunity and humoral immunity in non-A, non-B hepatitis].[非甲非乙型肝炎中的细胞免疫与体液免疫]
Nihon Rinsho. 1988 Dec;46(12):2624-8.
8
[New views on immunopathology of viral hepatitis B and C].[关于乙型和丙型病毒性肝炎免疫病理学的新观点]
Cas Lek Cesk. 2003;142(10):590-4.
9
[Suppressor T cell function and T cell autologous hepatotoxicity in chronic active hepatitis B].
Zhonghua Yi Xue Za Zhi. 1986 Sep;66(9):519-20, 574.
10
Induction of strong cytotoxic T-lymphocyte responses to hepatitis C virus with recombinant poly-epitope in BALB/c mice.重组多表位诱导BALB/c小鼠对丙型肝炎病毒产生强烈的细胞毒性T淋巴细胞反应。
Viral Immunol. 2006 Spring;19(1):64-73. doi: 10.1089/vim.2006.19.64.
引用本文的文献
1
Pathogenicity and virulence of lumpy skin disease virus: A comprehensive update.结节性皮肤病病毒的致病性和毒力：全面更新
Virulence. 2025 Dec;16(1):2495108. doi: 10.1080/21505594.2025.2495108. Epub 2025 Apr 27.
2
Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms.免疫有效生物材料增强型疫苗预防病原微生物感染
Biosaf Health. 2022 Dec 2;5(1):45-61. doi: 10.1016/j.bsheal.2022.11.002. eCollection 2023 Feb.
3
Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC).新型肝癌生物标志物肝癌特异性丝氨酸蛋白酶抑制剂卡扎尔型（LC-SPIK）的三维结构及其在肝细胞癌（HCC）临床诊断中的性能
Diagnostics (Basel). 2024 Mar 29;14(7):725. doi: 10.3390/diagnostics14070725.
4
Identification of miR-29a as a novel biomarker for lumpy skin disease virus exposure in cattle.鉴定 miR-29a 作为牛传染性块状皮肤病病毒暴露的新型生物标志物。
Virulence. 2024 Dec;15(1):2324711. doi: 10.1080/21505594.2024.2324711. Epub 2024 Mar 25.
5
AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy.腺相关病毒免疫毒性：在抗乙肝病毒基因治疗中的意义
Microorganisms. 2023 Dec 14;11(12):2985. doi: 10.3390/microorganisms11122985.
6
Antigen Recognition and Immune Response to Acute and Chronic Hepatitis B Virus Infection.急性和慢性乙型肝炎病毒感染的抗原识别与免疫反应
J Inflamm Res. 2023 May 18;16:2159-2166. doi: 10.2147/JIR.S411492. eCollection 2023.
7
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization.早期且在正确位置采取行动：SARS-CoV-2 细胞动力学和组织定位。
Int J Mol Sci. 2022 Sep 14;23(18):10679. doi: 10.3390/ijms231810679.
8
Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19.新冠疫情期间血液肿瘤领域乙肝病毒再激活的预防
Pathogens. 2022 May 11;11(5):567. doi: 10.3390/pathogens11050567.
9
Maternal immune activation and dietary soy isoflavone supplementation influence pig immune function but not muscle fiber formation.母体免疫激活和饮食大豆异黄酮补充会影响猪的免疫功能，但不会影响肌肉纤维的形成。
J Anim Sci. 2022 May 1;100(5). doi: 10.1093/jas/skac134.
10
CD4 T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy.慢性乙型肝炎中的 CD4 T 细胞和 T 细胞靶向免疫治疗。
Cells. 2021 May 6;10(5):1114. doi: 10.3390/cells10051114.
本文引用的文献
1
Posttranscriptional regulation of hepatitis B virus replication by the precore protein.前核心蛋白对乙型肝炎病毒复制的转录后调控
J Virol. 1997 Jan;71(1):345-53. doi: 10.1128/JVI.71.1.345-353.1997.
2
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines.慢性丙型肝炎感染中的进行性肝损伤与Th1相关细胞因子肝内表达增加相关。
Hepatology. 1996 Oct;24(4):759-65. doi: 10.1002/hep.510240402.
3
The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.尽管细胞毒性T淋巴细胞反应持续活跃，但乙肝病毒在患者从急性病毒性肝炎中康复后仍会持续数十年。
Nat Med. 1996 Oct;2(10):1104-8. doi: 10.1038/nm1096-1104.
4
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者外周血细胞毒性T淋巴细胞反应的定量分析。
J Clin Invest. 1996 Sep 15;98(6):1432-40. doi: 10.1172/JCI118931.
5
The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice.乙肝病毒（HBV）前核心蛋白抑制转基因小鼠体内的HBV复制。
J Virol. 1996 Oct;70(10):7056-61. doi: 10.1128/JVI.70.10.7056-7061.1996.
6
Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.病毒间相互作用：肝脏发生无关病毒感染时乙型肝炎病毒的细胞内失活
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4589-94. doi: 10.1073/pnas.93.10.4589.
7
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.慢性乙型肝炎病毒感染消退后的细胞毒性T淋巴细胞反应性。
J Clin Invest. 1996 Apr 1;97(7):1655-65. doi: 10.1172/JCI118592.
8
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.细胞毒性T淋巴细胞对乙型肝炎病毒的细胞内灭活作用。
Immunity. 1996 Jan;4(1):25-36. doi: 10.1016/s1074-7613(00)80295-2.
9
Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
Am J Gastroenterol. 1994 Jan;89(1):92-6.
10
Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.I类限制性免疫病理学机制。暴发性肝炎的转基因小鼠模型。
J Exp Med. 1993 Nov 1;178(5):1541-54. doi: 10.1084/jem.178.5.1541.
Zotero 插件